drugset / Trial / NCT03192566

Acetaminophen Dosing in Obese Adolescents

NCT03192566

Phase 3 Suspended 6 enrolled Children's National Research Institute
NaSingle-groupOpen-labelTreatment

Summary

Although there are numerous studies investigating the pharmacokinetic properties of intravenous acetaminophen in infants and children with normal weight, there are none in the obese pediatric patient . This study will investigate the pharmacokinetics and pharmacodynamics of acetaminophen (total Cl and Vd) in obese children and adolescents

Timeline

Start
2016-08
Primary completion
2024-08
Completion
2025-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg Intravenous
Subject Acetaminophen Small molecule 1 g Intravenous

Indications